News

Updates in relapsing-remitting MS from AAN 2025 examine neurofilament light protein level as a prognostic biomarker, safety and efficacy of ofatumumab, and benefit of early initiation of ozanimod.
In a phase 3 trial, 81% of wounds treated with autologous cell sheet-based gene therapy showed ≥ 50% healing at 6 months, ...
These are very interesting results that are helping people recognize what I think they already knew, which is the importance ...
Technology is a potent force that can either nourish or erode cognitive health depending on how it’s used. How can clinicians ...
Navigating the job market as a new physician? Learn tips on starting your search early, personal priorities, and more expert ...
US mortality rates are higher than Europe’s across all wealth groups, with cultural and systemic factors like diet, smoking, and rural living playing a major role.
Guideline-recommended mineralocorticoid receptor antagonists remain underused in patients with HFrEF in the United Kingdom, ...
Fewer than half of the adolescents prescribed a selective serotonin reuptake inhibitor (SSRI) at two large Chicago pediatric ...
The proportion of adolescents living with overweight and obesity in England increased by 50% over 15 years, and many related ...
Egor Chumakov, MD, PhD, adult psychiatrist and head of the Day Psychiatric Clinic in St. Petersburg Mental Health Hospital No ...
A survey of US dermatologists highlights inconsistent screening practices for comorbidities in patients with lichen planus.
New data presented at AACR supports adding pembrolizumab before and after surgery in patients with newly diagnosed locally ...